PAQ Therapeutics Funding: $30M Raised, Series A (2021)
PAQ Therapeutics is based in Burlington. It has raised $30M in total funding. Latest round: Series A.
PAQ Therapeutics funding overview
PAQ Therapeutics is based in Burlington. PAQ Therapeutics has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2021. The round record for PAQ Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Sherpa Healthcare Partners, Huagai Capital, MSA Capital, MRL Ventures Fund, Nest.Bio Ventures, Matrix Partners China and 2 others. 8 distinct backers are named across the disclosed rounds.
PAQ Therapeutics at a glance
Total raised
$30M
Latest round
Series A
Latest round date
July 2021
Headquarters
Burlington
Notable investors
Sherpa Healthcare Partners, Huagai Capital, MSA Capital, MRL Ventures Fund, Nest.Bio Ventures, Matrix Partners China, Merck, Johnson & Johnson
Frequently asked about PAQ Therapeutics funding
How much has PAQ Therapeutics raised?
PAQ Therapeutics has raised $30M in total disclosed funding across the rounds on record.
Who has invested in PAQ Therapeutics?
Sherpa Healthcare Partners, Huagai Capital, MSA Capital, MRL Ventures Fund, Nest.Bio Ventures, Matrix Partners China are named among the investors backing PAQ Therapeutics.
What was the latest PAQ Therapeutics funding round?
The most recent disclosed round is a Series A, announced in July 2021.
Where is PAQ Therapeutics based?
PAQ Therapeutics is based in Burlington.
When did PAQ Therapeutics last raise?
The last disclosed PAQ Therapeutics round closed in July 2021 at Series A.
Every PAQ Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Burlington at a similar stage.
